chr10-133127318-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001083909.3(ADGRA1):c.487G>A(p.Glu163Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000376 in 1,597,820 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001083909.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADGRA1 | NM_001083909.3 | c.487G>A | p.Glu163Lys | missense_variant | 6/7 | ENST00000392607.8 | |
ADGRA1 | NM_001291085.2 | c.196G>A | p.Glu66Lys | missense_variant | 3/4 | ||
ADGRA1 | XM_011540273.1 | c.-21G>A | 5_prime_UTR_variant | 2/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADGRA1 | ENST00000392607.8 | c.487G>A | p.Glu163Lys | missense_variant | 6/7 | 5 | NM_001083909.3 | P1 | |
ADGRA1 | ENST00000392606.2 | c.196G>A | p.Glu66Lys | missense_variant | 3/4 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152154Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000346 AC: 5AN: 1445666Hom.: 0 Cov.: 30 AF XY: 0.00000139 AC XY: 1AN XY: 718916
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152154Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 29, 2024 | The c.487G>A (p.E163K) alteration is located in exon 6 (coding exon 5) of the ADGRA1 gene. This alteration results from a G to A substitution at nucleotide position 487, causing the glutamic acid (E) at amino acid position 163 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at